(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AKR1C2 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1353901 6480464 epigallocatechin gallate results in increased expression of AKR1C2 mRNA CTD PMID:32512070 (20S)-20-hydroxypregn-4-en-3-one increases chemical synthesis ISO RGD:1353901 6480464 AKR1C2 protein results in increased chemical synthesis of 20-alpha-Dihydroprogesterone CTD PMID:11158055 (E)-cinnamyl alcohol increases activity ISO RGD:1353901 6480464 cinnamyl alcohol results in increased activity of AKR1C2 promoter CTD PMID:21195160 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1353901 6480464 o, p'-DDT results in increased expression of AKR1C2 mRNA CTD PMID:18204070 1,10-phenanthroline decreases activity ISO RGD:1353901 6480464 1, 10-phenanthroline results in decreased activity of AKR1C2 protein CTD PMID:12604236 1,2-dimethylhydrazine increases expression ISO RGD:1323510 6480464 1, 2-Dimethylhydrazine results in increased expression of AKR1C21 mRNA CTD PMID:22206623 1,3-benzothiazole-2-thiol increases activity ISO RGD:1353901 6480464 captax results in increased activity of AKR1C2 promoter CTD PMID:21195160 1,3-benzothiazole-2-thiol increases expression ISO RGD:1353901 6480464 captax results in increased expression of AKR1C2 mRNA CTD PMID:20491607 , PMID:20713136 1,4-benzoquinone increases expression ISO RGD:1353901 6480464 quinone results in increased expression of AKR1C2 mRNA CTD PMID:20491607 1,4-phenylenediamine increases activity ISO RGD:1353901 6480464 4-phenylenediamine results in increased activity of AKR1C2 promoter CTD PMID:21195160 1,4-phenylenediamine increases expression ISO RGD:1353901 6480464 4-phenylenediamine results in increased expression of AKR1C2 mRNA CTD PMID:20491607 , PMID:25724174 1-chloro-2,4-dinitrobenzene increases activity ISO RGD:1353901 6480464 Dinitrochlorobenzene results in increased activity of AKR1C2 promoter CTD PMID:21195160 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1353901 6480464 Dinitrochlorobenzene results in increased expression of AKR1C2 mRNA CTD PMID:20491607 , PMID:20713136 1-phenyl-1,2-propanedione increases expression ISO RGD:1353901 6480464 1-phenyl-1, 2-propanedione results in increased expression of AKR1C2 mRNA CTD PMID:20491607 17alpha-ethynylestradiol affects expression ISO RGD:1323510 6480464 Ethinyl Estradiol affects the expression of AKR1C21 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO RGD:1353901 6480464 Estradiol results in increased expression of AKR1C2 mRNA CTD PMID:19619570 17beta-estradiol multiple interactions ISO RGD:1353901 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of AKR1C2 mRNA CTD PMID:19619570 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:1353901 6480464 AKR1C2 protein results in increased metabolism of and results in decreased activity of Dihydrotestosterone, Flufenamic Acid inhibits the reaction [AKR1C2 protein results in increased metabolism of Dihydrotestosterone] CTD PMID:14672942 , PMID:17170221 17beta-hydroxy-5alpha-androstan-3-one increases metabolic processing ISO RGD:1353901 6480464 AKR1C2 protein results in increased metabolism of Dihydrotestosterone CTD PMID:14672942 , PMID:22245609 17beta-hydroxy-5alpha-androstan-3-one increases reduction ISO RGD:1353901 6480464 AKR1C2 protein results in increased reduction of Dihydrotestosterone CTD PMID:11158055 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1353901 6480464 2 more ... CTD PMID:25305463 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1353901 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of AKR1C2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1353901 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKR1C2 mRNA CTD PMID:19619570 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1353901 6480464 Trinitrobenzenesulfonic Acid results in increased expression of AKR1C2 mRNA CTD PMID:25724174 2-(chloromethyl)pyridine increases expression ISO RGD:1353901 6480464 2-chloromethylpyridine results in increased expression of AKR1C2 mRNA CTD PMID:26198647 2-aminophenol increases expression ISO RGD:1353901 6480464 2-aminophenol results in increased expression of AKR1C2 mRNA CTD PMID:20491607 2-hexenal increases expression ISO RGD:1353901 6480464 2-hexenal results in increased expression of AKR1C2 mRNA CTD PMID:20491607 2-hydroxyethyl methacrylate increases expression ISO RGD:1353901 6480464 hydroxyethyl methacrylate results in increased expression of AKR1C2 mRNA CTD PMID:30497689 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:30744511 3,3',5-triiodo-L-thyronine increases expression ISO RGD:1353901 6480464 Triiodothyronine results in increased expression of AKR1C2 mRNA CTD PMID:15507505 3,4,5,3',4',5'-Hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:30744511 3,4-dichloroaniline increases expression ISO RGD:1353901 6480464 3, 4-dichloroaniline results in increased expression of AKR1C2 mRNA CTD PMID:24172598 3-Nitrobenzanthrone increases reduction ISO RGD:1353901 6480464 AKR1C2 protein results in increased reduction of 3-nitrobenzanthrone CTD PMID:30406992 3-Nitrobenzanthrone multiple interactions ISO RGD:1353901 6480464 [AKR1C2 protein results in increased reduction of 3-nitrobenzanthrone] which results in increased chemical synthesis of 3-aminobenzanthrone, [AKR1C2 protein results in increased reduction of 3-nitrobenzanthrone] which results in increased chemical synthesis of N-hydroxy-3-aminobenzanthrone CTD PMID:30406992 3-phenylprop-2-enal increases activity ISO RGD:1353901 6480464 cinnamaldehyde results in increased activity of AKR1C2 promoter CTD PMID:21195160 3-phenylprop-2-enal multiple interactions ISO RGD:1353901 6480464 NFE2L2 mRNA promotes the reaction [cinnamaldehyde results in increased expression of AKR1C2 mRNA] CTD PMID:26244607 3-phenylprop-2-enal increases expression ISO RGD:1353901 6480464 cinnamaldehyde results in increased expression of AKR1C2 mRNA CTD PMID:25724174 , PMID:26244607 3alpha-hydroxy-5beta-pregnan-20-one increases reduction ISO RGD:1353901 6480464 AKR1C2 protein results in increased reduction of Pregnanolone CTD PMID:11995921 3alpha-hydroxy-5beta-pregnan-20-one affects metabolic processing ISO RGD:1353901 6480464 AKR1C2 protein affects the metabolism of Pregnanolone CTD PMID:12604236 4,4'-diaminodiphenylmethane increases expression ISO RGD:1323510 6480464 4, 4'-diaminodiphenylmethane results in increased expression of AKR1C21 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1353901 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of AKR1C2 protein CTD PMID:34186270 4-(ethoxymethylene)-2-phenyloxazol-5-one increases activity ISO RGD:1353901 6480464 Oxazolone results in increased activity of AKR1C2 promoter CTD PMID:21195160 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases metabolic processing ISO RGD:1353901 6480464 AKR1C2 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:11306090 4-hydroxybenzoic acid decreases activity ISO RGD:1353901 6480464 4-hydroxybenzoic acid analog results in decreased activity of AKR1C2 protein CTD PMID:27163852 4-nitro-1,2-phenylenediamine increases expression ISO RGD:1353901 6480464 1, 2-diamino-4-nitrobenzene results in increased expression of AKR1C2 mRNA CTD PMID:26198647 4-nitrobenzyl bromide increases activity ISO RGD:1353901 6480464 4-nitrobenzyl bromide results in increased activity of AKR1C2 promoter CTD PMID:21195160 4-nitrobenzyl bromide increases expression ISO RGD:1353901 6480464 4-nitrobenzyl bromide results in increased expression of AKR1C2 mRNA CTD PMID:25724174 5-alpha-THDOC affects oxidation ISO RGD:1353901 6480464 AKR1C2 protein affects the oxidation of tetrahydrodeoxycorticosterone CTD PMID:12604236 5-fluorouracil affects response to substance ISO RGD:1353901 6480464 AKR1C2 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 5alpha-pregnane-3,20-dione affects reduction ISO RGD:1353901 6480464 AKR1C2 protein affects the reduction of 5-alpha-Dihydroprogesterone CTD PMID:12604236 5alpha-pregnane-3,20-dione increases reduction ISO RGD:1353901 6480464 AKR1C2 protein results in increased reduction of 5-alpha-Dihydroprogesterone CTD PMID:11995921 9,10-phenanthroquinone increases metabolic processing ISO RGD:1353901 6480464 AKR1C2 protein results in increased metabolism of 9, 10-phenanthrenequinone CTD PMID:17950253 9,10-phenanthroquinone increases reduction ISO RGD:1353901 6480464 AKR1C2 protein results in increased reduction of 9, 10-phenanthrenequinone CTD PMID:21851338 , PMID:23261716 9,10-phenanthroquinone multiple interactions ISO RGD:1353901 6480464 AKR1C2 protein results in increased reduction of and affects the activity of 9, 10-phenanthrenequinone CTD PMID:21910479 acetylsalicylic acid decreases activity ISO RGD:1353901 6480464 Aspirin results in decreased activity of AKR1C2 protein CTD PMID:19010312 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of AKR1C2 mRNA CTD PMID:28959563 adefovir pivoxil decreases expression ISO RGD:1353901 6480464 adefovir dipivoxil results in decreased expression of AKR1C2 mRNA CTD PMID:25596134 aflatoxin B1 decreases methylation ISO RGD:1353901 6480464 Aflatoxin B1 results in decreased methylation of AKR1C2 gene CTD PMID:27153756 ampicillin decreases expression ISO RGD:1353901 6480464 Ampicillin results in decreased expression of AKR1C2 mRNA CTD PMID:21632981 androstane-3,17-diol increases chemical synthesis ISO RGD:1353901 6480464 AKR1C2 protein results in increased chemical synthesis of Androstane-3, 17-diol CTD PMID:11158055 , PMID:17170221 arsane multiple interactions ISO RGD:1353901 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1C2 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1353901 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1C2 mRNA CTD PMID:32525701 arsenous acid decreases response to substance ISO RGD:1353901 6480464 AKR1C2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 arsenous acid increases expression ISO RGD:1353901 6480464 Arsenic Trioxide results in increased expression of AKR1C2 mRNA CTD PMID:21461292 , PMID:26705709 arsenous acid multiple interactions ISO RGD:1353901 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR1C2 protein] CTD PMID:26598702 avobenzone increases expression ISO RGD:1353901 6480464 avobenzone results in increased expression of AKR1C2 mRNA CTD PMID:31016361 azathioprine increases expression ISO RGD:1353901 6480464 Azathioprine results in increased expression of AKR1C2 mRNA CTD PMID:22623647 , PMID:26198647 benzbromarone decreases activity ISO RGD:1353901 6480464 Benzbromarone results in decreased activity of AKR1C2 protein CTD PMID:12604236 benzo[a]pyrene affects response to substance ISO RGD:1353901 6480464 AKR1C2 protein affects the susceptibility to Benzo(a)pyrene CTD PMID:19800895 benzo[a]pyrene affects methylation ISO RGD:1353901 6480464 Benzo(a)pyrene affects the methylation of AKR1C2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1353901 6480464 Benzo(a)pyrene results in increased expression of AKR1C2 mRNA CTD PMID:15735009 more ... benzo[a]pyrene multiple interactions ISO RGD:1323510 6480464 [Tetradecanoylphorbol Acetate co-treated with Benzo(a)pyrene co-treated with Particulate Matter] results in increased expression of AKR1C21 mRNA CTD PMID:18353537 benzo[a]pyrene multiple interactions ISO RGD:1353901 6480464 [Particulate Matter co-treated with Benzo(a)pyrene] results in increased expression of AKR1C2 mRNA more ... CTD PMID:17612574 , PMID:19800895 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1353901 6480464 7 more ... CTD PMID:19150397 Benzo[a]pyrene-7,8-diol multiple interactions ISO RGD:1353901 6480464 [AKR1C2 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7, 8-dihydrodiol CTD PMID:21910479 benzo[a]pyrene-7,8-dione multiple interactions ISO RGD:1353901 6480464 [AKR1C2 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7, 8-dione CTD PMID:21910479 benzyl cinnamate increases expression ISO RGD:1353901 6480464 benzyl cinnamate results in increased expression of AKR1C2 mRNA CTD PMID:20491607 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1353901 6480464 Diethylhexyl Phthalate results in increased expression of AKR1C2 mRNA CTD PMID:28412506 bisphenol A affects expression ISO RGD:1353901 6480464 bisphenol A affects the expression of AKR1C2 mRNA CTD PMID:30903817 bisphenol A decreases methylation ISO RGD:1353901 6480464 bisphenol A results in decreased methylation of AKR1C2 gene CTD PMID:31601247 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AKR1C2 mRNA CTD PMID:30903817 Bisphenol B increases expression ISO RGD:1353901 6480464 bisphenol B results in increased expression of AKR1C2 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1353901 6480464 bisphenol F results in increased expression of AKR1C2 protein CTD PMID:34186270 bortezomib affects expression ISO RGD:1353901 6480464 Bortezomib affects the expression of AKR1C2 mRNA CTD PMID:21215737 cadmium atom increases expression ISO RGD:1353901 6480464 Cadmium results in increased expression of AKR1C2 mRNA CTD PMID:21120746 , PMID:21172416 cadmium atom multiple interactions ISO RGD:1353901 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR1C2 mRNA CTD PMID:29741670 cadmium dichloride affects expression ISO RGD:1353901 6480464 Cadmium Chloride affects the expression of AKR1C2 mRNA CTD PMID:23828170 cadmium dichloride multiple interactions ISO RGD:1353901 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR1C2 mRNA CTD PMID:29741670 cadmium dichloride increases expression ISO RGD:1353901 6480464 Cadmium Chloride results in increased expression of AKR1C2 mRNA CTD PMID:25596134 cadmium sulfate multiple interactions ISO RGD:1353901 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of AKR1C2 mRNA CTD PMID:18654764 celastrol increases expression ISO RGD:1353901 6480464 celastrol results in increased expression of AKR1C2 mRNA CTD PMID:17010675 chenodeoxycholic acid affects binding ISO RGD:1353901 6480464 Chenodeoxycholic Acid binds to AKR1C2 protein CTD PMID:8486699 chenodeoxycholic acid decreases activity ISO RGD:1353901 6480464 Chenodeoxycholic Acid results in decreased activity of AKR1C2 protein CTD PMID:8573067 chlorambucil decreases expression ISO RGD:1353901 6480464 Chlorambucil results in decreased expression of AKR1C2 mRNA CTD PMID:26198647 chloroacetaldehyde increases expression ISO RGD:1353901 6480464 chloroacetaldehyde results in increased expression of AKR1C2 mRNA CTD PMID:25596134 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of AKR1C2 mRNA CTD PMID:30744511 chloromethylisothiazolinone increases activity ISO RGD:1353901 6480464 5-chloro-2-methyl-4-isothiazolin-3-one results in increased activity of AKR1C2 promoter CTD PMID:21195160 chloropicrin affects expression ISO RGD:1353901 6480464 chloropicrin affects the expression of AKR1C2 mRNA CTD PMID:26352163 chloropicrin increases expression ISO RGD:1353901 6480464 chloropicrin results in increased expression of AKR1C2 mRNA CTD PMID:28476498 cidofovir anhydrous affects expression ISO RGD:1353901 6480464 Cidofovir affects the expression of AKR1C2 mRNA CTD PMID:25596134 ciglitazone multiple interactions ISO RGD:1353901 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of AKR1C2 mRNA, [ciglitazone binds to PPARG protein] which results in increased expression of AKR1C2 mRNA CTD PMID:16197558 cinnamyl alcohol increases activity ISO RGD:1353901 6480464 cinnamyl alcohol results in increased activity of AKR1C2 promoter CTD PMID:21195160 cisplatin decreases response to substance ISO RGD:1353901 6480464 AKR1C2 protein results in decreased susceptibility to Cisplatin CTD PMID:20953859 cisplatin multiple interactions ISO RGD:1353901 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of AKR1C2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1353901 6480464 Cisplatin results in decreased expression of AKR1C2 mRNA CTD PMID:26198647 cisplatin increases expression ISO RGD:1353901 6480464 Cisplatin results in increased expression of AKR1C2 mRNA CTD PMID:25596134 citral increases expression ISO RGD:1353901 6480464 citral results in increased expression of AKR1C2 mRNA CTD PMID:20491607 citral increases activity ISO RGD:1353901 6480464 citral results in increased activity of AKR1C2 promoter CTD PMID:21195160 clodronic acid increases expression ISO RGD:1353901 6480464 Clodronic Acid results in increased expression of AKR1C2 mRNA CTD PMID:25596134 Clofop increases reduction ISO RGD:1353901 6480464 AKR1C2 protein results in increased reduction of fenofibric acid CTD PMID:27599626 cloxazolam decreases activity ISO RGD:1353901 6480464 cloxazolam results in decreased activity of AKR1C2 protein CTD PMID:12604236 cobalt dichloride multiple interactions ISO RGD:1353901 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of AKR1C2 mRNA CTD PMID:18654764 coniferyl aldehyde increases expression ISO RGD:1353901 6480464 coniferaldehyde results in increased expression of AKR1C2 mRNA, coniferaldehyde results in increased expression of AKR1C2 protein CTD PMID:26275128 copper atom multiple interactions ISO RGD:1353901 6480464 [NSC 689534 binds to Copper] which results in increased expression of AKR1C2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1353901 6480464 [NSC 689534 binds to Copper] which results in increased expression of AKR1C2 mRNA CTD PMID:20971185 crocidolite asbestos decreases expression ISO RGD:1353901 6480464 Asbestos, Crocidolite results in decreased expression of AKR1C2 mRNA CTD PMID:18687144 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of AKR1C2 mRNA CTD PMID:26577399 cyclopentanol increases oxidation ISO RGD:1353901 6480464 AKR1C2 protein results in increased oxidation of cyclopentanol CTD PMID:23261716 cyclopentanone increases reduction ISO RGD:1353901 6480464 AKR1C2 protein results in increased reduction of cyclopentanone CTD PMID:23261716 cyclopentanone multiple interactions ISO RGD:1353901 6480464 [AKR1C2 protein co-treated with NADP] results in increased reduction of cyclopentanone more ... CTD PMID:23261716 cyclosporin A increases expression ISO RGD:1353901 6480464 Cyclosporine results in increased expression of AKR1C2 mRNA CTD PMID:22147139 more ... diarsenic trioxide increases expression ISO RGD:1353901 6480464 Arsenic Trioxide results in increased expression of AKR1C2 mRNA CTD PMID:21461292 , PMID:26705709 diarsenic trioxide multiple interactions ISO RGD:1353901 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR1C2 protein] CTD PMID:26598702 diarsenic trioxide decreases response to substance ISO RGD:1353901 6480464 AKR1C2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diazepam decreases activity ISO RGD:1353901 6480464 Diazepam results in decreased activity of AKR1C2 protein CTD PMID:11995921 , PMID:12604236 dibenzo[a,l]pyrene multiple interactions ISO RGD:1353901 6480464 [Particulate Matter co-treated with dibenzo(a more ... CTD PMID:17612574 dienogest decreases expression ISO RGD:1353901 6480464 dienogest results in decreased expression of AKR1C2 mRNA CTD PMID:23183084 diethyl maleate increases expression ISO RGD:1353901 6480464 diethyl maleate results in increased expression of AKR1C2 mRNA CTD PMID:20491607 diethyl sulfate increases expression ISO RGD:1353901 6480464 diethyl sulfate results in increased expression of AKR1C2 mRNA CTD PMID:20491607 dioxygen decreases expression ISO RGD:1353901 6480464 Oxygen deficiency results in decreased expression of AKR1C2 mRNA CTD PMID:25596134 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression ISO RGD:1353901 6480464 Antimony Potassium Tartrate results in increased expression of AKR1C2 protein CTD PMID:28713220 diquat increases expression ISO RGD:1353901 6480464 Diquat results in increased expression of AKR1C2 mRNA CTD PMID:21172416 diuron increases expression ISO RGD:1353901 6480464 Diuron metabolite results in increased expression of AKR1C2 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:1353901 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1353901 6480464 Doxorubicin results in decreased expression of AKR1C2 mRNA CTD PMID:29803840 dutasteride increases expression ISO RGD:1353901 6480464 Dutasteride results in increased expression of AKR1C2 mRNA CTD PMID:16806904 dydrogesterone decreases activity ISO RGD:1353901 6480464 Dydrogesterone results in decreased activity of AKR1C2 protein CTD PMID:22245609 dydrogesterone decreases expression ISO RGD:1353901 6480464 Dydrogesterone results in decreased expression of AKR1C2 mRNA CTD PMID:23183084 entinostat decreases expression ISO RGD:1353901 6480464 entinostat results in decreased expression of AKR1C2 mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:1323510 6480464 epoxiconazole results in increased expression of AKR1C21 mRNA CTD PMID:35436446 estazolam decreases activity ISO RGD:1353901 6480464 Estazolam results in decreased activity of AKR1C2 protein CTD PMID:11995921 Ethyl acrylate increases expression ISO RGD:1353901 6480464 ethyl acrylate results in increased expression of AKR1C2 mRNA CTD PMID:26198647 ethyl methanesulfonate increases expression ISO RGD:1353901 6480464 Ethyl Methanesulfonate results in increased expression of AKR1C2 mRNA CTD PMID:23649840 ethylene glycol dimethacrylate increases activity ISO RGD:1353901 6480464 ethylene dimethacrylate results in increased activity of AKR1C2 promoter CTD PMID:21195160 eugenol increases expression ISO RGD:1353901 6480464 Eugenol results in increased expression of AKR1C2 mRNA CTD PMID:26198647 farnesal increases expression ISO RGD:1353901 6480464 farnesal results in increased expression of AKR1C2 mRNA CTD PMID:20491607 fenamic acid decreases activity ISO RGD:1353901 6480464 fenamic acid analog results in decreased activity of AKR1C2 protein CTD PMID:19010312 fenofibrate increases expression ISO RGD:1353901 6480464 Fenofibrate results in increased expression of AKR1C2 mRNA CTD PMID:25596134 flufenamic acid multiple interactions ISO RGD:1353901 6480464 Flufenamic Acid inhibits the reaction [AKR1C2 protein results in increased metabolism of Dihydrotestosterone] CTD PMID:14672942 flufenamic acid decreases activity ISO RGD:1353901 6480464 Flufenamic Acid results in decreased activity of AKR1C2 protein CTD PMID:12604236 , PMID:8573067 flunitrazepam decreases activity ISO RGD:1353901 6480464 Flunitrazepam results in decreased activity of AKR1C2 protein CTD PMID:11995921 fluorescein 5-isothiocyanate increases expression ISO RGD:1353901 6480464 Fluorescein-5-isothiocyanate results in increased expression of AKR1C2 mRNA CTD PMID:20491607 flurbiprofen decreases activity ISO RGD:1353901 6480464 Flurbiprofen results in decreased activity of AKR1C2 protein CTD PMID:19010312 folic acid increases expression ISO RGD:1323510 6480464 Folic Acid results in increased expression of AKR1C21 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1353901 6480464 Formaldehyde results in increased expression of AKR1C2 mRNA CTD PMID:20491607 , PMID:20655997 gedunin increases expression ISO RGD:1353901 6480464 gedunin results in increased expression of AKR1C2 mRNA CTD PMID:17010675 geranial increases expression ISO RGD:1353901 6480464 citral results in increased expression of AKR1C2 mRNA CTD PMID:20491607 geranial increases activity ISO RGD:1353901 6480464 citral results in increased activity of AKR1C2 promoter CTD PMID:21195160 glipizide decreases activity ISO RGD:1353901 6480464 Glipizide results in decreased activity of AKR1C2 protein CTD PMID:26362498 glyburide decreases activity ISO RGD:1353901 6480464 Glyburide results in decreased activity of AKR1C2 protein CTD PMID:26362498 glycyrrhetinate decreases activity ISO RGD:1353901 6480464 Glycyrrhetinic Acid results in decreased activity of AKR1C2 protein CTD PMID:12604236 glycyrrhetinic acid decreases activity ISO RGD:1353901 6480464 Glycyrrhetinic Acid results in decreased activity of AKR1C2 protein CTD PMID:12604236 glyoxal increases activity ISO RGD:1353901 6480464 Glyoxal results in increased activity of AKR1C2 promoter CTD PMID:21195160 glyoxal increases expression ISO RGD:1353901 6480464 Glyoxal results in increased expression of AKR1C2 mRNA CTD PMID:25724174 gold atom increases expression ISO RGD:1353901 6480464 Gold results in increased expression of AKR1C2 mRNA CTD PMID:29705079 gold(0) increases expression ISO RGD:1353901 6480464 Gold results in increased expression of AKR1C2 mRNA CTD PMID:29705079 hexestrol decreases activity ISO RGD:1353901 6480464 Hexestrol results in decreased activity of AKR1C2 protein CTD PMID:12604236 , PMID:8573067 hydralazine multiple interactions ISO RGD:1353901 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1C2 mRNA CTD PMID:17183730 hydrogen peroxide increases expression ISO RGD:1353901 6480464 Hydrogen Peroxide results in increased expression of AKR1C2 mRNA CTD PMID:12414654 hydrogen peroxide affects expression ISO RGD:1353901 6480464 Hydrogen Peroxide affects the expression of AKR1C2 mRNA CTD PMID:23410634 hydrogen peroxide multiple interactions ISO RGD:1353901 6480464 [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of AKR1C2 mRNA, [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of AKR1C2 protein CTD PMID:19320734 ibuprofen decreases activity ISO RGD:1353901 6480464 Ibuprofen results in decreased activity of AKR1C2 protein CTD PMID:19010312 , PMID:8573067 ifosfamide increases expression ISO RGD:1353901 6480464 Ifosfamide results in increased expression of AKR1C2 mRNA CTD PMID:25596134 imidurea increases activity ISO RGD:1353901 6480464 imidazolidinyl urea results in increased activity of AKR1C2 promoter CTD PMID:21195160 indometacin decreases activity ISO RGD:1353901 6480464 Indomethacin results in decreased activity of AKR1C2 protein CTD PMID:12604236 more ... isoeugenol increases expression ISO RGD:1353901 6480464 isoeugenol results in increased expression of AKR1C2 mRNA CTD PMID:20491607 isoeugenol increases activity ISO RGD:1353901 6480464 isoeugenol results in increased activity of AKR1C2 promoter CTD PMID:21195160 ivermectin decreases expression ISO RGD:1353901 6480464 Ivermectin results in decreased expression of AKR1C2 protein CTD PMID:32959892 L-ascorbic acid increases expression ISO RGD:1353901 6480464 Ascorbic Acid results in increased expression of AKR1C2 mRNA CTD PMID:26198647 lead diacetate increases expression ISO RGD:1353901 6480464 lead acetate results in increased expression of AKR1C2 mRNA CTD PMID:22839698 lead(0) affects splicing ISO RGD:1353901 6480464 Lead affects the splicing of AKR1C2 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:1353901 6480464 Lead affects the splicing of AKR1C2 mRNA CTD PMID:28903495 lead(II) chloride multiple interactions ISO RGD:1353901 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of AKR1C2 mRNA CTD PMID:18654764 lead(II) chloride increases expression ISO RGD:1353901 6480464 lead chloride results in increased expression of AKR1C2 mRNA CTD PMID:18654764 linalool increases expression ISO RGD:1353901 6480464 linalool results in increased expression of AKR1C2 mRNA CTD PMID:20491607 lithocholic acid affects binding ISO RGD:1353901 6480464 AKR1C2 protein binds to Lithocholic Acid, Lithocholic Acid binds to AKR1C2 protein CTD PMID:8486699 , PMID:8573067 lithocholic acid decreases activity ISO RGD:1353901 6480464 Lithocholic Acid results in decreased activity of AKR1C2 protein CTD PMID:12604236 , PMID:8573067 malathion increases expression ISO RGD:1353901 6480464 Malathion results in increased expression of AKR1C2 mRNA CTD PMID:16079077 meclofenamic acid decreases activity ISO RGD:1353901 6480464 Meclofenamic Acid results in decreased activity of AKR1C2 protein CTD PMID:19010312 more ... Medazepam decreases activity ISO RGD:1353901 6480464 Medazepam results in decreased activity of AKR1C2 protein CTD PMID:11995921 , PMID:12604236 medroxyprogesterone acetate decreases activity ISO RGD:1353901 6480464 Medroxyprogesterone Acetate results in decreased activity of AKR1C2 protein CTD PMID:12604236 , PMID:22245609 mefenamic acid decreases activity ISO RGD:1353901 6480464 Mefenamic Acid analog results in decreased activity of AKR1C2 protein CTD PMID:19010312 menadione increases expression ISO RGD:1353901 6480464 Vitamin K 3 results in increased expression of AKR1C2 mRNA CTD PMID:12414654 , PMID:23410634 mercury dibromide increases expression ISO RGD:1353901 6480464 mercuric bromide results in increased expression of AKR1C2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1353901 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C2 mRNA CTD PMID:27188386 methyl methanesulfonate increases expression ISO RGD:1353901 6480464 Methyl Methanesulfonate results in increased expression of AKR1C2 mRNA CTD PMID:23649840 methyl non-2-ynoate increases expression ISO RGD:1353901 6480464 2-nonynoic acid methyl ester results in increased expression of AKR1C2 mRNA CTD PMID:20491607 methylmercury chloride increases expression ISO RGD:1353901 6480464 methylmercuric chloride results in increased expression of AKR1C2 mRNA CTD PMID:28001369 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of AKR1C2 mRNA CTD PMID:30744511 n-propyl gallate increases expression ISO RGD:1353901 6480464 Propyl Gallate results in increased expression of AKR1C2 mRNA CTD PMID:20491607 NAD zwitterion multiple interactions ISO RGD:1353901 6480464 [AKR1C2 protein co-treated with NAD] results in increased oxidation of acenaphthene-1-ol more ... CTD PMID:25446855 NAD(+) multiple interactions ISO RGD:1353901 6480464 [AKR1C2 protein co-treated with NAD] results in increased oxidation of acenaphthene-1-ol more ... CTD PMID:25446855 NADP zwitterion multiple interactions ISO RGD:1353901 6480464 [AKR1C2 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7 more ... CTD PMID:14672942 more ... NADP(+) multiple interactions ISO RGD:1353901 6480464 [AKR1C2 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7 more ... CTD PMID:14672942 more ... naphthalenes multiple interactions ISO RGD:1353901 6480464 AKR1C2 protein results in increased reduction of and affects the activity of Naphthalenes CTD PMID:21910479 naproxen decreases activity ISO RGD:1353901 6480464 Naproxen results in decreased activity of AKR1C2 protein CTD PMID:19010312 nitrazepam decreases activity ISO RGD:1353901 6480464 Nitrazepam results in decreased activity of AKR1C2 protein CTD PMID:11995921 ochratoxin A decreases expression ISO RGD:1353901 6480464 ochratoxin A results in decreased expression of AKR1C2 mRNA CTD PMID:19287073 , PMID:32905824 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of AKR1C2 mRNA CTD PMID:30449730 octadecanoic acid increases expression ISO RGD:1353901 6480464 stearic acid results in increased expression of AKR1C2 mRNA CTD PMID:32347412 octyl gallate decreases activity ISO RGD:1353901 6480464 octyl gallate results in decreased activity of AKR1C2 protein CTD PMID:27163852 oxcarbazepine increases reduction ISO RGD:1353901 6480464 AKR1C2 protein results in increased reduction of oxcarbazepine CTD PMID:25063510 p-chloromercuribenzoic acid increases expression ISO RGD:1353901 6480464 p-Chloromercuribenzoic Acid results in increased expression of AKR1C2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1353901 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C2 mRNA CTD PMID:27188386 paclitaxel increases response to substance ISO RGD:1353901 6480464 AKR1C2 mRNA results in increased susceptibility to Paclitaxel CTD PMID:16322897 para-Cresidine increases expression ISO RGD:1353901 6480464 cresidine results in increased expression of AKR1C2 mRNA CTD PMID:26198647 paracetamol decreases expression ISO RGD:1353901 6480464 Acetaminophen results in decreased expression of AKR1C2 mRNA CTD PMID:29067470 Paraoxon-methyl multiple interactions ISO RGD:1353901 6480464 AKR1C2 protein affects the susceptibility to [Benzo(a)pyrene co-treated with methylparaoxon] CTD PMID:19800895 Paraoxon-methyl increases expression ISO RGD:1353901 6480464 methylparaoxon results in increased expression of AKR1C2 mRNA CTD PMID:19800895 parathion-methyl multiple interactions ISO RGD:1353901 6480464 AKR1C2 protein affects the susceptibility to [Benzo(a)pyrene co-treated with Methyl Parathion] more ... CTD PMID:19800895 parathion-methyl increases expression ISO RGD:1353901 6480464 Methyl Parathion results in increased expression of AKR1C2 mRNA CTD PMID:19800895 parathion-methyl increases activity ISO RGD:1353901 6480464 Methyl Parathion results in increased activity of AKR1C2 protein CTD PMID:19800895 perfluorooctanoic acid decreases expression ISO RGD:1323510 6480464 perfluorooctanoic acid results in decreased expression of AKR1C2 mRNA CTD PMID:17681415 phenethyl caffeate decreases activity ISO RGD:1353901 6480464 caffeic acid phenethyl ester results in decreased activity of AKR1C2 protein CTD PMID:27163852 phenolphthalein decreases activity ISO RGD:1353901 6480464 Phenolphthalein results in decreased activity of AKR1C2 protein CTD PMID:12604236 Phenyl glycidyl ether multiple interactions ISO RGD:1353901 6480464 phenylglycidyl ether analog promotes the reaction [NFE2L2 protein results in increased expression of AKR1C2 mRNA] CTD PMID:21751775 phenylacetaldehyde increases expression ISO RGD:1353901 6480464 phenylacetaldehyde results in increased expression of AKR1C2 mRNA CTD PMID:20491607 phenylmercury acetate increases expression ISO RGD:1353901 6480464 Phenylmercuric Acetate results in increased expression of AKR1C2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1353901 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C2 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1323510 6480464 [Tetradecanoylphorbol Acetate co-treated with Benzo(a)pyrene co-treated with Particulate Matter] results in increased expression of AKR1C21 mRNA CTD PMID:18353537 phorbol 13-acetate 12-myristate decreases expression ISO RGD:1353901 6480464 Tetradecanoylphorbol Acetate results in decreased expression of AKR1C2 mRNA CTD PMID:26198647 pirinixic acid decreases expression ISO RGD:1323510 6480464 pirinixic acid results in decreased expression of AKR1C2 mRNA CTD PMID:18467677 pirinixic acid increases expression ISO RGD:1323510 6480464 pirinixic acid results in increased expression of AKR1C21 mRNA CTD PMID:20813756 pirinixic acid multiple interactions ISO RGD:1323510 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of AKR1C2 mRNA] CTD PMID:18467677 potassium bromate increases expression EXP 6480464 potassium bromate results in increased expression of AKR1C2 mRNA CTD PMID:23588252 progesterone increases reduction ISO RGD:1353901 6480464 AKR1C2 protein results in increased reduction of Progesterone CTD PMID:11158055 more ... prostaglandin F2alpha increases metabolic processing ISO RGD:1353901 6480464 AKR1C2 protein results in increased metabolism of Dinoprost CTD PMID:8573067 quercetin decreases expression ISO RGD:1353901 6480464 Quercetin results in decreased expression of AKR1C2 mRNA CTD PMID:21632981 quinolin-8-ol increases expression ISO RGD:1353901 6480464 Oxyquinoline results in increased expression of AKR1C2 mRNA CTD PMID:21632981 , PMID:26198647 reactive oxygen species multiple interactions ISO RGD:1353901 6480464 [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of AKR1C2 mRNA, [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of AKR1C2 protein CTD PMID:19320734 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of AKR1C2 mRNA CTD PMID:28374803 salicylic acid decreases activity ISO RGD:1353901 6480464 Salicylic Acid results in decreased activity of AKR1C2 protein CTD PMID:19010312 salicylic acid increases expression ISO RGD:1353901 6480464 Salicylic Acid results in increased expression of AKR1C2 mRNA CTD PMID:20491607 SB 431542 multiple interactions ISO RGD:1353901 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases secretion ISO RGD:1353901 6480464 Silicon Dioxide analog results in increased secretion of AKR1C2 protein CTD PMID:25895662 silver atom increases expression ISO RGD:1353901 6480464 Silver results in increased expression of AKR1C2 mRNA CTD PMID:28959546 silver(0) increases expression ISO RGD:1353901 6480464 Silver results in increased expression of AKR1C2 mRNA CTD PMID:28959546 sodium arsenate multiple interactions ISO RGD:1353901 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1C2 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:1353901 6480464 sodium arsenite results in increased expression of AKR1C2 mRNA, sodium arsenite results in increased expression of AKR1C2 protein CTD PMID:19696165 more ... sodium dodecyl sulfate increases expression ISO RGD:1353901 6480464 Sodium Dodecyl Sulfate results in increased expression of AKR1C2 mRNA CTD PMID:20491607 sulforaphane increases expression ISO RGD:1353901 6480464 sulforaphane results in increased expression of AKR1C2 mRNA CTD PMID:24383545 , PMID:31746589 sulindac decreases activity ISO RGD:1353901 6480464 Sulindac results in decreased activity of AKR1C2 protein CTD PMID:19010312 tert-butyl hydroperoxide increases expression ISO RGD:1353901 6480464 tert-Butylhydroperoxide results in increased expression of AKR1C2 mRNA CTD PMID:12414654 more ... testosterone decreases expression ISO RGD:1353901 6480464 Testosterone results in decreased expression of AKR1C2 mRNA CTD PMID:33359661 testosterone enanthate affects expression ISO RGD:1353901 6480464 testosterone enanthate affects the expression of AKR1C2 mRNA CTD PMID:17440010 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AKR1C2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of AKR1C2 mRNA CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of AKR1C2 mRNA CTD PMID:34492290 thiram increases activity ISO RGD:1353901 6480464 Thiram results in increased activity of AKR1C2 promoter CTD PMID:21195160 titanium dioxide decreases phosphorylation ISO RGD:1353901 6480464 titanium dioxide results in decreased phosphorylation of AKR1C2 protein CTD PMID:21439344 trans-isoeugenol increases activity ISO RGD:1353901 6480464 isoeugenol results in increased activity of AKR1C2 promoter CTD PMID:21195160 trans-isoeugenol increases expression ISO RGD:1353901 6480464 isoeugenol results in increased expression of AKR1C2 mRNA CTD PMID:20491607 Tributyltin oxide increases expression ISO RGD:1353901 6480464 bis(tri-n-butyltin)oxide results in increased expression of AKR1C2 mRNA CTD PMID:26198647 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of AKR1C2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1353901 6480464 trichostatin A results in increased expression of AKR1C2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1353901 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C2 mRNA CTD PMID:27188386 tris(2-butoxyethyl) phosphate decreases expression ISO RGD:1353901 6480464 tris(2-butoxyethyl) phosphate results in decreased expression of AKR1C2 mRNA CTD PMID:29024780 tunicamycin increases expression ISO RGD:1323510 6480464 Tunicamycin results in increased expression of AKR1C21 mRNA CTD PMID:17127020 urethane decreases expression ISO RGD:1353901 6480464 Urethane results in decreased expression of AKR1C2 mRNA CTD PMID:28818685 ursodeoxycholic acid multiple interactions ISO RGD:1353901 6480464 Ursodeoxycholic Acid inhibits the reaction [[AKR1C2 protein co-treated with NADP] results in increased reduction of cyclopentanone] CTD PMID:23261716 ursodeoxycholic acid decreases activity ISO RGD:1353901 6480464 Ursodeoxycholic Acid results in decreased activity of AKR1C2 protein CTD PMID:12604236 more ... valproic acid decreases methylation ISO RGD:1353901 6480464 Valproic Acid results in decreased methylation of AKR1C2 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1353901 6480464 Valproic Acid results in increased expression of AKR1C2 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1353901 6480464 Valproic Acid affects the expression of AKR1C2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1353901 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1C2 mRNA more ... CTD PMID:17183730 , PMID:27188386 vanillin increases expression ISO RGD:1353901 6480464 vanillin results in increased expression of AKR1C2 mRNA CTD PMID:20491607 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of AKR1C2 gene CTD PMID:31079544 vitamin E increases expression ISO RGD:1353901 6480464 Vitamin E results in increased expression of AKR1C2 mRNA CTD PMID:19244175 vorinostat increases expression ISO RGD:1353901 6480464 vorinostat results in increased expression of AKR1C2 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:1353901 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C2 mRNA CTD PMID:27188386 zinc sulfate increases expression ISO RGD:1353901 6480464 Zinc Sulfate results in increased expression of AKR1C2 mRNA CTD PMID:16330358 zoledronic acid decreases expression ISO RGD:1353901 6480464 zoledronic acid results in decreased expression of AKR1C2 mRNA CTD PMID:25596134 zomepirac decreases activity ISO RGD:1353901 6480464 zomepirac results in decreased activity of AKR1C2 protein CTD PMID:19010312